Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Fluomizin for Local Treatment of Bacterial Vaginosis
2006-004398-89Phase 3Completed
- Sponsor
- Medinova AG
- Start
- Sep 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dequalinium in bacterial vaginosis (BV) (2 arms), sponsored by Medinova AG. Primary endpoint: Clinical cure rate at visit C1 based on Amsel criteria. Started Sep 2006; status: completed.
02
Drugs
dequalinium
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on 2006-004398-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004398-89.